Improving outcomes in state AIDS drug assistance programs.
Improving outcomes in state AIDS drug assistance programs.
复制标题
改善州艾滋病药物援助计划的成果。
DOI：
10.1097/qai.0b013e3181b16d00
复制
发表时间：
2009
期刊：
影响因子：
--
通讯作者：
Freedberg,KennethA
中科院分区：
文献类型：
--
作者：
Linas,BenjaminP;Losina,Elena;Rockwell,Annette;Walensky,RochelleP;Cranston,Kevin;Freedberg,KennethA
Background:State AIDS Drug Assistance Programs (ADAPs) provide antiretroviral medications to patients with no access to medications. Resource constraints limit the ability of many ADAPs to meet demand for services.Objective:To determine ADAP eligibility criteria that minimize morbidity and mortality and contain costs.Methods:We used Discrete Event Simulation to model the progression of HIV-infected patients and track the utilization of an ADAP. Outcomes included 5-year mortality and incidence of first opportunistic infection or death and time to starting antiretroviral therapy (ART). We compared expected outcomes for 2 policies:(1) first-come first-served (FCFS) eligibility for all with CD4 count≤ 350/μL (current standard) and (2) CD4 count prioritized eligibility for those with CD4 counts below a defined threshold.Results:In the base case, prioritizing patients with CD4 counts≤ 250/μL led to lower 5-year mortality than FCFS eligibility (2.77 vs. 3.27 deaths per 1000 person-months) and to a lower incidence of first opportunistic infection or death (5.55 vs. 6.98 events per 1000 person-months). CD4-based eligibility reduced the time to starting ART for patients with CD4 counts≤ 200/μL. In sensitivity analyses, CD4-based eligibility consistently led to lower morbidity and mortality than FCFS eligibility.Conclusion:When resources are limited, programs that provide ART can improve outcomes by prioritizing patients with low CD4 counts.
